Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Cancer Letters 337 (2013) 226-236].

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Chen J, Su C.

Cancer Lett. 2020 Jan 22. pii: S0304-3835(20)30022-7. doi: 10.1016/j.canlet.2020.01.014. [Epub ahead of print] No abstract available.

PMID:
31982228
2.

Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Chen J, Su C.

Cancer Lett. 2020 Mar 31;473:198-199. doi: 10.1016/j.canlet.2019.12.034. Epub 2020 Jan 8. No abstract available.

PMID:
31926781
3.

Competitive Adsorption of Methanol-Acetone on Surface Functionalization (-COOH, -OH, -NH2, and -SO3H): Grand Canonical Monte Carlo and Density Functional Theory Simulations.

Guo Y, Zeng Z, Li L, Su C, Chen R, Wang C, Zhou K, Xu X, Li H.

ACS Appl Mater Interfaces. 2019 Sep 18;11(37):34241-34250. doi: 10.1021/acsami.9b10804. Epub 2019 Sep 10.

PMID:
31462036
4.

Extracellular Vesicles-Derived OncomiRs Mediate Communication between Cancer Cells and Cancer-Associated Hepatic Stellate Cells in Hepatocellular Carcinoma Microenvironment.

Li J, Yan Y, Ang L, Li X, Liu C, Sun B, Lin X, Peng Z, Zhang X, Zhang Q, Wu H, Zhao M, Su C.

Carcinogenesis. 2019 May 29. pii: bgz096. doi: 10.1093/carcin/bgz096. [Epub ahead of print]

PMID:
31140556
5.

Acetone adsorption capacity of sulfur-doped microporous activated carbons prepared from polythiophene.

Zhu J, Chen R, Zeng Z, Su C, Zhou K, Mo Y, Guo Y, Zhou F, Gao J, Li L.

Environ Sci Pollut Res Int. 2019 Jun;26(16):16166-16180. doi: 10.1007/s11356-019-05051-y. Epub 2019 Apr 10.

PMID:
30972669
6.

Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.

Zhang Q, Huang H, Liu A, Li J, Liu C, Sun B, Chen L, Gao Y, Xu D, Su C.

EBioMedicine. 2019 Apr;42:397-407. doi: 10.1016/j.ebiom.2019.03.032. Epub 2019 Mar 21.

7.

Design strategies and application progress of therapeutic exosomes.

Liu C, Su C.

Theranostics. 2019 Jan 30;9(4):1015-1028. doi: 10.7150/thno.30853. eCollection 2019. Review.

8.

Catalytic performance of potassium in lignocellulosic biomass pyrolysis based on an optimized three-parallel distributed activation energy model.

Wang C, Li L, Zeng Z, Xu X, Ma X, Chen R, Su C.

Bioresour Technol. 2019 Jun;281:412-420. doi: 10.1016/j.biortech.2019.02.118. Epub 2019 Feb 27.

PMID:
30849697
9.

Estimates of parameters for formaldehyde emission model from plywood panel under various temperature and relative humidity conditions.

Su C, Ming H, Yang Y, Ma W, Li H, Li L.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2019;54(1):48-55. doi: 10.1080/10934529.2018.1511363. Epub 2018 Sep 19.

PMID:
30230958
10.

Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma.

Yin H, Que R, Liu C, Ji W, Sun B, Lin X, Zhang Q, Zhao X, Peng Z, Zhang X, Qian H, Chen L, Yao Y, Su C.

Cancer Lett. 2018 Jul 1;425:54-64. doi: 10.1016/j.canlet.2018.03.044. Epub 2018 Mar 30.

PMID:
29608986
11.

I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.

Wu L, Sun B, Lin X, Liu C, Qian H, Chen L, Yang Y, Shen F, Su C.

Genes Cells. 2018 Jan;23(1):35-45. doi: 10.1111/gtc.12545. Epub 2017 Dec 6.

12.

Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.

Feng SD, Mao Z, Liu C, Nie YS, Sun B, Guo M, Su C.

Onco Targets Ther. 2017 Nov 23;10:5591-5604. doi: 10.2147/OTT.S149632. eCollection 2017.

13.

PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development.

Mao Z, Liu C, Lin X, Sun B, Su C.

Cancer Lett. 2018 Feb 1;414:222-229. doi: 10.1016/j.canlet.2017.11.024. Epub 2017 Nov 23. Review.

PMID:
29175459
14.

A rapid quantitative analysis of bile acids, lysophosphatidylcholines and polyunsaturated fatty acids in biofluids based on ultraperformance liquid chromatography coupled with triple quadrupole tandem massspectrometry.

Peng Z, Zhang Q, Mao Z, Wang J, Liu C, Lin X, Li X, Ji W, Fan J, Wang M, Su C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Nov 15;1068-1069:343-351. doi: 10.1016/j.jchromb.2017.10.066. Epub 2017 Nov 6.

PMID:
29129603
15.

Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.

Li C, Zhu M, Lou X, Liu C, Chen H, Lin X, Ji W, Li Z, Su C.

Oncotarget. 2017 May 20;8(42):71933-71945. doi: 10.18632/oncotarget.18035. eCollection 2017 Sep 22.

16.
17.

Targeting MicroRNAs in Cancer Gene Therapy.

Ji W, Sun B, Su C.

Genes (Basel). 2017 Jan 9;8(1). pii: E21. doi: 10.3390/genes8010021. Review.

18.

Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.

Lin X, Peng Z, Fu X, Liu C, Xu Y, Ji W, Fan J, Chen L, Fang L, Huang Y, Su C.

Oncotarget. 2016 Nov 29;7(48):79761-79773. doi: 10.18632/oncotarget.12962.

19.

Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.

Lou X, Sun B, Song J, Wang Y, Jiang J, Xu Y, Ren Z, Su C.

Oncotarget. 2016 Dec 20;7(51):84486-84495. doi: 10.18632/oncotarget.12996.

20.

Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.

Cheng S, Yang J, Shen F, Zhou W, Wang Y, Cong W, Yang GS, Cheng H, Hu H, Gao C, Guo J, Li A, Meng Y, Jiang X, Yang Y, Qian G, Luo M, Hu B, Man X, Zhang B, Su C, Zhou F, Li N, Shi J, Wang M, Zheng Y, Guo W, Sun J, Wang H, Lau WY, Wu MC.

Oncotarget. 2016 Jun 28;7(26):40816-40829. doi: 10.18632/oncotarget.8386. Review.

Supplemental Content

Loading ...
Support Center